Tiziana Life Sciences (TLSA) Current Leases (2019 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Current Leases of $222000.0 for Q4 2025, up 109.43% year-over-year from $106000.0 in Q4 2024, and up 107.48% quarter-over-quarter from $107000.0 in Q2 2025.
Tiziana Life Sciences (TLSA) Current Leases (2019 - 2025) Analysis & Trends
Tiziana Life Sciences' Current Leases history runs 7 years deep, the most recent figure standing at $222000.0 for Q4 2025.
- In Q4 2025, Current Leases rose 109.43% year-over-year to $222000.0; the TTM figure through Dec 2025 stood at $222000.0 (up 109.43% YoY), while the FY2025 annual figure was $222000.0, up 109.43% from the prior year.
- Current Leases for Q4 2025 stood at $222000.0, up from $107000.0 in the prior quarter.
- The five-year high for Current Leases was $232000.0 in Q2 2021, with the low at $106000.0 in Q4 2024.
- The 5-year median for Current Leases is $140000.0 (2023), against an average of $156500.0.
- Peak annual rise in Current Leases reached 109.43% in 2025, while the deepest fall reached 24.65% in 2025.
- Tiziana Life Sciences' Current Leases stood at $232000.0 in 2021, then plunged by 47.41% to $122000.0 in 2022, then gained by 13.11% to $138000.0 in 2023, then decreased by 23.19% to $106000.0 in 2024, then jumped by 109.43% to $222000.0 in 2025.
- Business Quant data shows TLSA's Current Leases at $222000.0 in Q4 2025, $107000.0 in Q2 2025, and $106000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Tiziana Life Sciences | 133.07 Mn | 129.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 222,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Jun 30, 2023 | 183,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Jun 30, 2021 | 232,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Dec 31, 2019 | 528,432.94 |
| Jun 30, 2019 | 111,909.20 |